What is EDDA Technology?
EDDA Technology, established in 2003 and headquartered in New Jersey, United States, specializes in providing computer assistance for the patient care management cycle. The company's core focus is on enabling early detection and diagnosis of diseases through advanced technological solutions. This strategic positioning within the healthcare technology sector, particularly in diagnostic assistance and patient management, places EDDA Technology at the intersection of medical innovation and data-driven healthcare.
How much funding has EDDA Technology raised?
EDDA Technology has raised a total of $150.3M across 2 funding rounds:
Debt
$350K
Other Financing Round
$150M
Debt (2020): $350K with participation from PPP
Other Financing Round (2021): $150M led by The Morningside Group, SoftBank Group Corp., OrbiMed, BOCGI, The Bridge, Matrix Partners China, 3W Fund, Sbcvc, and Draper Dragon
Key Investors in EDDA Technology
SoftBank Group Corp.
SoftBank Group Corp. is a global technology holding company driving innovation across telecommunications, internet services, artificial intelligence, smart robotics, IoT, and clean energy technologies. Through its diverse portfolio of companies and strategic investments, including leading semiconductor IP providers, SoftBank Group supports the development and scaling of transformative technologies worldwide.
OrbiMed
OrbiMed Advisors LLC operates as a specialized investment firm focused on the healthcare sector, with deep expertise spanning multiple therapeutic and commercial domains. The firm manages capital across biopharmaceuticals, medical devices, digital health platforms, diagnostics, and healthcare services, bringing together investment professionals with extensive experience in life sciences and healthcare business development.
Matrix Partners China
Founded in 1977, Matrix Partners operates as a venture capital firm. The Company invests in software and services, communications equipment, semiconductors, storage, internet, and wireless sectors. The company is headquartered in San Francisco, California.
What's next for EDDA Technology?
The substantial enterprise-level funding and recent strategic investment suggest EDDA Technology is poised for significant scaling and market expansion. This capital infusion is likely to accelerate product development, enhance its diagnostic capabilities, and broaden its reach within the healthcare industry. The company's focus on early disease detection and patient care management aligns with global trends towards preventative healthcare and the increasing adoption of AI in medical diagnostics. Future growth may involve strategic partnerships, further technological advancements, and increased market penetration, solidifying its role as a key player in health tech.
See full EDDA Technology company page
